<PAGE>

        UNITED STATES SECURITIES AND EXCHANGE COMMISSION


                      WASHINGTON, DC  20549


                            FORM 8-K

                         CURRENT REPORT


               PURSUANT TO SECTION 13 OR 15(d) OF
               THE SECURITIES EXCHANGE ACT OF 1934


Date of Report (Date of earliest event reported):  March 1, 2001


                     GERBER SCIENTIFIC, INC.
                ----------------------------------
                   (Exact name of Registrant as
                    specified in its charter)


           CONNECTICUT              1-5865          06-0640743
 ------------------------------  ------------  -------------------
  (State or other jurisdiction    (Commission    (I.R.S. Employer
       of incorporation or         File No.)   Identification No.)
          organization)


 83 Gerber Road West, South Windsor, Connecticut         06074
--------------------------------------------------  ---------------
     (Address of principal executive offices)         (Zip Code)



Registrant's Telephone Number, including area       (860) 644-1551
code:                                               ---------------



                         Not applicable
                     -----------------------
  (Former name or former address, if changes since last report)

<PAGE>

ITEM 9. REGULATION FD DISCLOSURE

See  the  following press release, dated March 1, 2001, announcing
the Company's third quarter results, strategic actions, and outlook:



Contact: Robert J. Goehring                 For Immediate Release
(860) 648-8041                                      March 1, 2001


     GERBER SCIENTIFIC, INC. REPORTS THIRD QUARTER RESULTS;
             ANNOUNCES STRATEGIC ACTIONS AND OUTLOOK


SOUTH  WINDSOR,  CT - Gerber Scientific, Inc. (NYSE:  GRB)  today
reported  financial results for the third quarter and first  nine
months  ended  January  31, 2001.  The  Company  highlighted  the
following:

Results
-------
  - Weaker economic conditions and strong dollar led to lower sales
    and a third quarter loss of $.17 per share;
  - Cash  flow from operations improved to $25.3 million for  the
    nine-month period this year;
  - Debt  reduced  by $27.3 million in the first nine  months  to
    $167.6 million;
  - Dividend will be suspended following February 28, 2001 payment;

Strategic Actions
-----------------
  - Major fourth quarter restructuring planned; Company estimates
    special charge of $20 to $22 million; annualized savings of $30
    to $35 million;
  - Strategic alternatives for optical business progressing;

Outlook
-------
  - For the fourth quarter, a loss of $.03 per share is expected
    before any special charges;
  - In  next  fiscal year, modest revenue growth to $560 to  $565
    million anticipated; improved earnings in range of $.45 to $.50
    per share.

Third Quarter Impacted by North American Economy, Strong Dollar
---------------------------------------------------------------

The  Company  reported a loss of $.17 per diluted share  for  the
third  quarter ended January 31, 2001 on sales of $134.2  million
compared with earnings of $.37 per share for the third quarter of
last year on sales of $155.5 million.  These amounts were in line
with  a previous announcement on February 23, 2001 regarding  the
Company's expected third quarter results.  The net loss  in  this
year's third quarter was $3.6 million, compared with net earnings
of $8.3 million for the same period last year.

For the first nine months of the current fiscal year, the Company
reported  a  loss per share of $.08 (before a special  charge  of
$.13  per share in the first quarter) on sales of $415.5 million.
After  the  special charge, the net loss per share for  the  nine
months  ended January 31, 2001 was $.20 (note that the per  share
amounts do not add due to rounding.)  These results compared with
earnings of $1.08 per diluted share for the same period last year
on  sales  of $447.9 million.  The net loss in this year's  first
nine  months was $1.7 million before the special charge and  $4.5
million after the charge, compared with earnings of $24.2 million
for the same period last year.

Commenting  on  the third quarter results, Michael  J.  Cheshire,
Chairman  and  Chief  Executive Officer, said,  "Orders  for  our
systems  in  North  America slowed dramatically  in  the  quarter
across all three businesses.  We are cautious about the near-term
outlook for capital equipment in general.  The cost reductions we
implemented  last  summer  were  not  enough  to  overcome   this
slowdown.   The  continued strength of  the  dollar  also  had  a
negative impact on our competitiveness, especially in Europe.  We
must  take  substantial  cost actions in light  of  the  changing
economic  conditions to ensure we emerge from the downturn  as  a
stronger, leaner, and more focused company."

Actions to Reduce Debt
----------------------

In  the first nine months of the current fiscal year, the Company
reported asset sales and improved working capital management  had
generated   improved  cash  flow,  despite  the  lower  operating
results.  Cash flow from operations amounted to $25.3 million for
the  first  nine months of this year compared with $14.2  million
for  the  same  period last year.  Reductions  in  the  Company's
working capital, particularly accounts receivable, contributed to
this  improvement.   Asset sales added to this amount,  including
approximately   $12.0  million  received  from  a  sale/leaseback
transaction  involving the Bristol, UK facility of the  Company's
Spandex  PLC  subsidiary.  The Company has reduced  its  debt  by
$27.3 million since the beginning of the current fiscal year  and
is  focused on generating additional cash flow to further  reduce
its debt level.  The Company remains committed to selling certain
idle  facilities and is negotiating an additional  sale/leaseback
transaction for its principal South Windsor, Connecticut, campus.
In  addition, the Company announced on February 23, 2001 that its
Board  of  Directors  had  voted to suspend  the  $.08  quarterly
dividend after the February 28, 2001 payment.  Suspension of  the
dividend will provide the Company with an additional $7.0 million
per year of cash flow to be used toward lowering debt.

Weaker Foreign Currencies Lower Results
---------------------------------------

As  in  previous  periods, weaker year-to-year  foreign  currency
exchange  rates substantially affected the Company's  results  in
the  three  and  nine  month  periods  ended  January  31,  2001.
Revenues  for  the  third quarter of $134.2  million  were  $21.3
million  lower than last year's comparable period, reflecting  in
part  an  $8.7  million  adverse  impact  from  foreign  currency
translation  rates  on  a year-to-year basis.   Holding  currency
values  constant, this year's first nine months revenue of $415.5
million  would have been $26.3 million higher, or $441.8 million,
more  in  line  with  last year's nine month  revenue  of  $447.9
million. Earnings per share were $.06 lower in this year's  third
quarter, and $.22 lower in this year's first nine months, due  to
weaker currency translation rates.

Profit Margins Impacted by Lower Revenue and Sales Mix
------------------------------------------------------

Profitability was impacted by top-line weakness in the  Company's
three  core businesses.  Each segment realized lower year-to-year
sales  in  both the third quarter and first nine months  of  this
year.   Profitability  was off substantially  on  a  year-to-year
basis  in  the  Company's  two largest operating  segments,  Sign
Making and Specialty Graphics and Apparel and Flexible Materials,
and to a lesser extent in the Optical Lens Processing segment.

As  was  the  case  in the prior quarter, profitability  in  this
year's third quarter and first nine months was also depressed  by
lower  gross margins.  The weaker foreign currency values lowered
gross  profit  margins  as did changes in the  sales  mix,  which
favored  higher  margin  products last year.   Additionally,  the
geographic shift of sales this year to international markets  had
an  adverse  impact  on margins, as the Company  generally  sells
through distributors and agents in those markets.

Orders Dampened by Market Weakness and Currency Effect on
Competitiveness
---------------------------------------------------------

Net  orders  totaled  $133.5 million for the three  months  ended
January  31, 2001, compared with $148.5 million last  year.   For
the first nine months of this year, new orders amounted to $412.1
million  compared  with $456.8 million last year.   Each  of  the
Company's operating segments reported lower orders in the current
year,  with  the  shortfalls occurring in both the  European  and
North  American  markets.   The  weaker  currencies  offered  the
Company's  European competitors pricing advantages,  particularly
in  that  geographic  market.  Weakening economic  conditions  in
North  American  markets  has  also  resulted  in  fewer  orders,
particularly  for  equipment.  Higher  orders  were  received  in
international  markets,  where  economic  conditions  have   been
improving.

Backlog at the end of this year's third quarter was $41.8 million
compared with $45.2 million at the beginning of the fiscal  year,
with  the  decrease occurring primarily in the  Sign  Making  and
Specialty Graphics segment.  Order entry in this segment has been
dampened  by  previously  reported problems  experienced  in  the
introduction  of  the  Gerber  MAXX, a  new  wide-format  thermal
imaging system.  Currently the MAXX is on technical hold, and the
Company  expects  to  resume shipments in the  next  fiscal  year
beginning May 2001.

Company to Restructure Operations, Take Charge
----------------------------------------------

The   Company   today  announced  there  will  be  a  substantial
restructuring  of  its  worldwide operations  with  the  goal  of
reducing  operating  costs by $30 to $35  million  on  an  annual
basis. In conjunction with this, the Company anticipates a fourth-
quarter charge in the range of $20 to $22 million before taxes to
cover  the  costs  associated  with  severance,  plant  closings,
product  line terminations, and other asset write-downs. As  part
of   these  actions,  the  Company  anticipates  a  reduction  of
approximately 350 to 400 employees worldwide, or about 13  to  15
percent of its current workforce.

Review of Strategic Alternatives for Optical Business Continues
---------------------------------------------------------------

As  previously reported, the Company is considering  a  range  of
strategic alternatives, including potential divestiture, for  its
optical lens processing unit, Gerber Coburn.  The Company expects
to   complete  its  evaluation  of  all  potential  options   and
alternatives prior to fiscal year end on April 30, 2001.

Outlook:  Fourth Quarter Loss Expected; Earnings to Improve Next
Fiscal Year
----------------------------------------------------------------

The Company also said that it expects sales in the fourth quarter
ending April 30, 2001 will be in the range of $145.0 million with
a  net  loss estimated in the range of $.7 million, or  $.03  per
share,  before  any special charge.  Based upon these  estimates,
the  Company's  sales for the fiscal year ending April  30,  2001
would be approximately $560.0 million with a loss in the range of
$5.2  million, or $.23 per share.  These amounts are also  before
the  charge anticipated in the fourth quarter associated with the
restructuring  of  operations, but do  include  a  first  quarter
special  charge of $2.8 million after taxes, or $.13  per  share.
This  compares with sales of $611.0 million and earnings of $1.16
per diluted share in the prior year.

Given   current  economic  conditions,  the  Company  anticipates
limited top line growth in its next fiscal year beginning May  1,
2001.   Preliminary estimates for fiscal year 2002 are for  sales
in  the range of $560 to $565 million.  Based largely on benefits
derived from the restructuring actions being taken in the  fourth
quarter, the Company anticipates earnings per share in the  range
of $.45 to $.50 next fiscal year.

Gerber Scientific, Inc. (http://www.gerberscientific.com) is  the
world's leading supplier of sophisticated automated manufacturing
systems  that  enable  mass  customization  in  sign  making  and
specialty graphics, apparel and flexible goods, and optical  lens
processing.   Headquartered  in South Windsor,  Connecticut,  the
Company operates through four wholly-owned subsidiaries:   Gerber
Scientific  Products  and  Spandex PLC,  Gerber  Technology,  and
Gerber Coburn.

In addition to the historical information contained herein, there
are  matters discussed that are considered to be "forward looking
statements."   The Private Securities Litigation  Reform  Act  of
1995  provides  a  "safe harbor" for forward-looking  statements.
These forward looking statements involve risks and uncertainties,
including,   but   not   limited   to,   economic,   competitive,
governmental,  and technological factors affecting the  Company's
operations,   markets,   products,  and  services,   that   could
significantly affect results in the future.  For a discussion  of
other  risk factors relating to the Company's business,  see  the
Company's  Quarterly Reports on Form 10-Q for the quarters  ended
July  31, 2000 and October 31, 2000 and its Annual Report on Form
10-K  for  the  year  ended April 30, 2000,  as  filed  with  the
Securities   and   Exchange   Commission.   The   forward-looking
statements contained in this release are made as of the  date  of
this release, and the Company assumes no obligation to update  or
revise any forward-looking statements contained in this release.


<PAGE>


              GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                  CONSOLIDATED SUMMARY OF EARNINGS

Comparison on a consolidated basis for the three and nine months ended
January 31, 2001 and 2000 as follows:

THIRD QUARTER FINANCIAL FIGURES FOR THREE AND NINE MONTHS ENDED
JANUARY 31, 2001 AND 2000
---------------------------------------------------------------------------
                           Three Months                 Nine Months
                     --------------------------  --------------------------
                             2001          2000          2001          2000
                     ------------  ------------  ------------  ------------

Sales                $134,245,000  $155,543,000  $415,489,000  $447,872,000
                      ===========   ===========   ===========   ===========
Earnings (loss)
 before special
 charge (1)          $ (2,940,000) $ 12,174,000  $    229,000  $ 36,557,000
Special charge (1)             --            --    (4,419,000)           --
                      -----------   -----------   -----------   -----------
Earnings (loss)
 before income
 taxes               $ (2,940,000) $ 12,174,000  $ (4,190,000) $ 36,557,000
                      -----------   -----------   -----------   -----------
Taxes on earnings
 before special
 charge (2)          $   (700,000) $ (3,900,000) $ (1,900,000) $(12,400,000)
Tax benefit on
 special charge                --            --     1,600,000            --
                      -----------   -----------   -----------   -----------
Provision for
 income taxes        $   (700,000) $ (3,900,000) $   (300,000) $(12,400,000)
                      -----------   -----------   -----------   -----------
Net earnings (loss)
 before special
 charge (1)          $ (3,640,000) $  8,274,000  $ (1,671,000) $ 24,157,000
Special charge, net
 of taxes (1)                  --            --    (2,819,000)           --
                      -----------   -----------   -----------   -----------
Net earnings (loss)  $ (3,640,000) $  8,274,000  $ (4,490,000) $ 24,157,000
                      ===========   ===========   ===========   ===========

Per Share of Common Stock

Basic (3)
 Before special
  charge             $       (.17) $        .37  $       (.08) $       1.09
 Special charge                --            --          (.13)           --
                      -----------   -----------   -----------   -----------
                     $       (.17) $        .37  $       (.20) $       1.09
                      ===========   ===========   ===========   ===========
Diluted (3)
 Before special
  charge             $       (.17) $        .37  $       (.08) $       1.08
 Special charge                --            --          (.13)           --
                      -----------   -----------   -----------   -----------
                     $       (.17) $        .37  $       (.20) $       1.08
                      ===========   ===========   ===========   ===========

Average Shares Outstanding

Basic                  22,025,000    22,193,000    22,010,000    22,167,000
                      ===========   ===========   ===========   ===========
Diluted                22,025,000    22,411,000    22,010,000    22,450,000
                      ===========   ===========   ===========   ===========


(1)   Included  in  the nine months ended January  31,  2001  was  a
special  charge related to a reduction in workforce, provisions  for
losses on the sale of facilities, and other asset impairments.  This
charge  amounted  to $4,419,000 before income taxes  and  $2,819,000
after taxes ($.13 per share on a diluted basis.)

(2)   The  income tax  expense in the third  quarter and nine months
ended January 31, 2001 arises principally from the non-deductibility
of goodwill amortization.

(3)   Earnings per share information is computed separately for each
period.   Therefore,  the sum of such quarterly  share  amounts  may
differ from the total for the year.

<PAGE>

              GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                 CONSOLIDATED STATEMENTS OF EARNINGS


                                          Three Months Ended
In thousands (except per share amounts)      January 31,
--------------------------------------   ---------------------
                                             2001         2000
                                         --------     --------
Revenue:

  Product sales                          $122,056     $141,997
  Service                                  12,189       13,546
                                          -------      -------
                                          134,245      155,543
                                          -------      -------

Costs and Expenses:

  Cost of product sales                    79,639       84,916
  Cost of service                           7,997        7,080
  Selling, general and administrative      36,937       38,534
  Research and development expenses         7,256        7,982
  Goodwill amortization                     2,237        2,103
                                          -------      -------
                                          134,066      140,615
                                          -------      -------

Operating income                              179       14,928

Other income (expense)                        289          (21)
Interest expense                           (3,408)      (2,733)
                                          -------      -------

Earnings (loss) before income taxes        (2,940)      12,174

Provision for income taxes                    700        3,900
                                          -------      -------
Net earnings (loss)                      $ (3,640)    $  8,274
                                          =======      =======
Per share of common stock:
  Basic                                  $   (.17)    $    .37
  Diluted                                $   (.17)    $    .37

  Dividends                              $    .08     $    .08

Average shares outstanding:
  Basic                                    22,025       22,193
  Diluted                                  22,025       22,411

                       See Accompanying Notes

<PAGE>

              GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                 CONSOLIDATED STATEMENTS OF EARNINGS


                                           Nine Months Ended
In thousands (except per share amounts)       January 31,
--------------------------------------   ---------------------
                                             2001         2000
                                         --------     --------
Revenue:

  Product sales                          $378,477     $407,451
  Service                                  37,012       40,421
                                          -------      -------
                                          415,489      447,872
                                          -------      -------

Costs and Expenses:

  Cost of product sales                   243,331      239,949
  Cost of service                          24,335       21,573
  Selling, general and administrative     108,706      112,068
  Research and development expenses        22,526       24,884
  Goodwill amortization                     6,713        6,353
  Special charge                            4,419           --
                                          -------      -------
                                          410,030      404,827
                                          -------      -------

Operating income                            5,459       43,045

Other income                                  395        1,116
Interest expense                          (10,044)      (7,604)
                                          -------      -------

Earnings (loss) before income taxes        (4,190)      36,557

Provision for income taxes                    300       12,400
                                          -------      -------
Net earnings (loss)                      $ (4,490)    $ 24,157
                                          =======      =======
Per share of common stock:
  Basic                                  $   (.20)    $   1.09
  Diluted                                $   (.20)    $   1.08

  Dividends                              $    .24     $    .24

Average shares outstanding:
  Basic                                    22,010       22,167
  Diluted                                  22,010       22,450

                       See Accompanying Notes

<PAGE>

               GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                     CONSOLIDATED BALANCE SHEETS


                                        January 31,    April 30,
In thousands                               2001           2000
-------------------------------------   -----------    ---------
Assets
Current Assets:
 Cash and short-term cash investments      $ 14,327     $ 22,954
 Accounts receivable                        100,319      121,494
 Inventories                                 89,727       86,472
 Prepaid expenses                            18,756       21,042
 Net assets held for sale                    23,270           --
                                            -------      -------
                                            246,399      251,962
                                            -------      -------
Property, Plant and Equipment               118,590      165,341
 Less accumulated depreciation               54,767       66,121
                                            -------      -------
                                             63,823       99,220
                                            -------      -------
Intangible Assets                           246,033      245,797
 Less accumulated amortization               34,829       27,419
                                            -------      -------
                                            211,204      218,378
                                            -------      -------
Other Assets                                  4,498        3,276
                                            -------      -------
                                           $525,924     $572,836
                                            =======      =======
Liabilities and Shareholders' Equity

Current Liabilities:
 Notes payable                             $     --    $      --
 Accounts payable                            48,752       58,043
 Accrued compensation and benefits           12,498       16,646
 Other accrued liabilities                   27,935       26,689
 Deferred revenue                             9,513        8,436
 Advances on sales contracts                  2,715        2,610
                                            -------      -------
                                            101,413      112,424
                                            -------      -------
Noncurrent Liabilities:
 Deferred income taxes                        8,295        8,608
 Long-term debt                             167,627      194,892
                                            -------      -------
                                            175,922      203,500
                                            -------      -------

Contingencies and Commitments

Shareholders' Equity:
 Preferred stock, no par value;
  authorized 10,000,000 shares;
  no shares issued                               --          --
 Common stock, $1.00 par value;
  authorized 65,000,000 shares;
  issued 22,827,309 and 22,779,651
  shares                                     22,827      22,780
 Paid-in capital                             43,853      43,615
 Retained earnings                          200,984     210,749
 Treasury stock, at cost (788,899
  and 797,444 shares, respectively)         (16,222)    (16,397)
 Unamortized value of restricted
  stock grants                                 (552)       (557)
 Accumulated other comprehensive
  income(loss)                               (2,301)     (3,278)
                                            -------     -------
                                            248,589     256,912
                                            -------     -------
                                           $525,924    $572,836
                                            =======     =======

                       See Accompanying Notes

<PAGE>

              GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                CONSOLIDATED STATEMENTS OF CASH FLOWS


In thousands                                         2001       2000
---------------------------------------------    --------   --------
Cash Provided by (Used for):
Operating Activities:
  Net earnings (loss)                            $ (4,490)  $ 24,157
  Adjustments to reconcile net earnings
  (loss)to cash provided by operating
  activities:
     Depreciation and amortization                 20,827     18,665
     Special charge                                 4,419         --
     Deferred income taxes                           (313)    (1,730)
     Other non-cash items                             399        324
     Changes in operating accounts, net of
      effects of business acquisitions:
      Receivables                                  21,175     (7,310)
      Inventories                                  (3,255)   (19,965)
      Prepaid expenses                              2,231      5,638
      Accounts payable and accrued expenses       (15,682)    (5,564)
                                                   ------     ------
Provided by Operating Activities                   25,311     14,215
                                                   ------     ------
Investing Activities:
  Additions to property, plant and equipment      (14,245)   (18,091)
  Proceeds from sale of assets                     13,721         --
  Business acquisitions                                --    (11,026)
  Intangible and other assets                      (1,749)    (1,156)
  Other, net                                          977     (1,660)
                                                   ------     ------
(Used for) Investing Activities                    (1,296)   (31,933)
                                                   ------     ------
Financing Activities:
  Additions of long-term debt                      34,000     40,566
  Repayments of long-term debt                    (61,265)   (20,133)
  Net short-term financing                             --     (1,497)
  Debt issue costs                                   (168)        --
  Proceeds from issuance of stock                      66      1,938
  Dividends on common stock                        (5,275)    (5,312)
                                                   ------     ------
Provided by (Used for) Financing Activities       (32,642)    15,562
                                                   ------     ------
(Decrease) in Cash and Short-Term
  Cash Investments                                 (8,627)    (2,156)
Cash and Short-Term Cash Investments,
  Beginning of Period                              22,954     26,523
                                                   ------     ------
Cash and Short-Term Cash Investments,            $ 14,327   $ 24,367
  End of Period                                    ======     ======
                       See Accompanying Notes

<PAGE>

                           SIGNATURES


Pursuant  to the requirements of the Securities Exchange  Act  of
1934, the Registrant has duly caused this report to be signed  on
its behalf by the undersigned hereunto duly authorized.




                            GERBER SCIENTIFIC, INC.
                            ------------------------
                                  (Registrant)



Date:   March 1, 2001       By:  / s / Gary K. Bennett
        ------------------       ---------------------------------
                                 Gary K. Bennett
                                 Senior Vice President, Finance
                                 (Principal Financial and
                                 Accounting Officer)
[{"type": "8-K", "sequence": "1", "filename": "0001.txt", "secsgml_size_bytes": 30170}]
{"company-data": {"conformed-name": "GERBER SCIENTIFIC INC", "cik": "0000041133", "assigned-sic": "3559", "irs-number": "060640743", "state-of-incorporation": "CT", "fiscal-year-end": "0430"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-05865", "film-number": "1558251"}, "business-address": {"street1": "83 GERBER RD WEST", "city": "SOUTH WINDSOR", "state": "CT", "zip": "06074", "phone": "8606441551"}, "mail-address": {"street1": "83 GERBER ROAD WESTS", "city": "SOUTH WINDSOR", "state": "CT", "zip": "06074"}, "former-company": {"former-conformed-name": "GERBER SCIENTIFIC INSTRUMENT CO", "date-changed": "19781210"}}
UNITED STATES SECURITIES AND EXCHANGE COMMISSION

                      WASHINGTON, DC  20549

                            FORM 8-K

                         CURRENT REPORT

               PURSUANT TO SECTION 13 OR 15(d) OF
               THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):  March 1, 2001

                     GERBER SCIENTIFIC, INC.
                ----------------------------------
                   (Exact name of Registrant as
                    specified in its charter)

           CONNECTICUT              1-5865          06-0640743
 ------------------------------  ------------  -------------------
  (State or other jurisdiction    (Commission    (I.R.S. Employer
       of incorporation or         File No.)   Identification No.)
          organization)

 83 Gerber Road West, South Windsor, Connecticut         06074
--------------------------------------------------  ---------------
     (Address of principal executive offices)         (Zip Code)

Registrant's Telephone Number, including area       (860) 644-1551
code:                                               ---------------

                         Not applicable
                     -----------------------
  (Former name or former address, if changes since last report)
ITEM 9. REGULATION FD DISCLOSURE

See  the  following press release, dated March 1, 2001, announcing
the Company's third quarter results, strategic actions, and outlook:

Contact: Robert J. Goehring                 For Immediate Release
(860) 648-8041                                      March 1, 2001

     GERBER SCIENTIFIC, INC. REPORTS THIRD QUARTER RESULTS;
             ANNOUNCES STRATEGIC ACTIONS AND OUTLOOK

SOUTH  WINDSOR,  CT - Gerber Scientific, Inc. (NYSE:  GRB)  today
reported  financial results for the third quarter and first  nine
months  ended  January  31, 2001.  The  Company  highlighted  the
following:

Results
-------
  - Weaker economic conditions and strong dollar led to lower sales
    and a third quarter loss of $.17 per share;
  - Cash  flow from operations improved to $25.3 million for  the
    nine-month period this year;
  - Debt  reduced  by $27.3 million in the first nine  months  to
    $167.6 million;
  - Dividend will be suspended following February 28, 2001 payment;

Strategic Actions
-----------------
  - Major fourth quarter restructuring planned; Company estimates
    special charge of $20 to $22 million; annualized savings of $30
    to $35 million;
  - Strategic alternatives for optical business progressing;

Outlook
-------
  - For the fourth quarter, a loss of $.03 per share is expected
    before any special charges;
  - In  next  fiscal year, modest revenue growth to $560 to  $565
    million anticipated; improved earnings in range of $.45 to $.50
    per share.

Third Quarter Impacted by North American Economy, Strong Dollar
---------------------------------------------------------------

The  Company  reported a loss of $.17 per diluted share  for  the
third  quarter ended January 31, 2001 on sales of $134.2  million
compared with earnings of $.37 per share for the third quarter of
last year on sales of $155.5 million.  These amounts were in line
with  a previous announcement on February 23, 2001 regarding  the
Company's expected third quarter results.  The net loss  in  this
year's third quarter was $3.6 million, compared with net earnings
of $8.3 million for the same period last year.

For the first nine months of the current fiscal year, the Company
reported  a  loss per share of $.08 (before a special  charge  of
$.13  per share in the first quarter) on sales of $415.5 million.
After  the  special charge, the net loss per share for  the  nine
months  ended January 31, 2001 was $.20 (note that the per  share
amounts do not add due to rounding.)  These results compared with
earnings of $1.08 per diluted share for the same period last year
on  sales  of $447.9 million.  The net loss in this year's  first
nine  months was $1.7 million before the special charge and  $4.5
million after the charge, compared with earnings of $24.2 million
for the same period last year.

Commenting  on  the third quarter results, Michael  J.  Cheshire,
Chairman  and  Chief  Executive Officer, said,  "Orders  for  our
systems  in  North  America slowed dramatically  in  the  quarter
across all three businesses.  We are cautious about the near-term
outlook for capital equipment in general.  The cost reductions we
implemented  last  summer  were  not  enough  to  overcome   this
slowdown.   The  continued strength of  the  dollar  also  had  a
negative impact on our competitiveness, especially in Europe.  We
must  take  substantial  cost actions in light  of  the  changing
economic  conditions to ensure we emerge from the downturn  as  a
stronger, leaner, and more focused company."

Actions to Reduce Debt
----------------------

In  the first nine months of the current fiscal year, the Company
reported asset sales and improved working capital management  had
generated   improved  cash  flow,  despite  the  lower  operating
results.  Cash flow from operations amounted to $25.3 million for
the  first  nine months of this year compared with $14.2  million
for  the  same  period last year.  Reductions  in  the  Company's
working capital, particularly accounts receivable, contributed to
this  improvement.   Asset sales added to this amount,  including
approximately   $12.0  million  received  from  a  sale/leaseback
transaction  involving the Bristol, UK facility of the  Company's
Spandex  PLC  subsidiary.  The Company has reduced  its  debt  by
$27.3 million since the beginning of the current fiscal year  and
is  focused on generating additional cash flow to further  reduce
its debt level.  The Company remains committed to selling certain
idle  facilities and is negotiating an additional  sale/leaseback
transaction for its principal South Windsor, Connecticut, campus.
In  addition, the Company announced on February 23, 2001 that its
Board  of  Directors  had  voted to suspend  the  $.08  quarterly
dividend after the February 28, 2001 payment.  Suspension of  the
dividend will provide the Company with an additional $7.0 million
per year of cash flow to be used toward lowering debt.

Weaker Foreign Currencies Lower Results
---------------------------------------

As  in  previous  periods, weaker year-to-year  foreign  currency
exchange  rates substantially affected the Company's  results  in
the  three  and  nine  month  periods  ended  January  31,  2001.
Revenues  for  the  third quarter of $134.2  million  were  $21.3
million  lower than last year's comparable period, reflecting  in
part  an  $8.7  million  adverse  impact  from  foreign  currency
translation  rates  on  a year-to-year basis.   Holding  currency
values  constant, this year's first nine months revenue of $415.5
million  would have been $26.3 million higher, or $441.8 million,
more  in  line  with  last year's nine month  revenue  of  $447.9
million. Earnings per share were $.06 lower in this year's  third
quarter, and $.22 lower in this year's first nine months, due  to
weaker currency translation rates.

Profit Margins Impacted by Lower Revenue and Sales Mix
------------------------------------------------------

Profitability was impacted by top-line weakness in the  Company's
three  core businesses.  Each segment realized lower year-to-year
sales  in  both the third quarter and first nine months  of  this
year.   Profitability  was off substantially  on  a  year-to-year
basis  in  the  Company's  two largest operating  segments,  Sign
Making and Specialty Graphics and Apparel and Flexible Materials,
and to a lesser extent in the Optical Lens Processing segment.

As  was  the  case  in the prior quarter, profitability  in  this
year's third quarter and first nine months was also depressed  by
lower  gross margins.  The weaker foreign currency values lowered
gross  profit  margins  as did changes in the  sales  mix,  which
favored  higher  margin  products last year.   Additionally,  the
geographic shift of sales this year to international markets  had
an  adverse  impact  on margins, as the Company  generally  sells
through distributors and agents in those markets.

Orders Dampened by Market Weakness and Currency Effect on
Competitiveness
---------------------------------------------------------

Net  orders  totaled  $133.5 million for the three  months  ended
January  31, 2001, compared with $148.5 million last  year.   For
the first nine months of this year, new orders amounted to $412.1
million  compared  with $456.8 million last year.   Each  of  the
Company's operating segments reported lower orders in the current
year,  with  the  shortfalls occurring in both the  European  and
North  American  markets.   The  weaker  currencies  offered  the
Company's  European competitors pricing advantages,  particularly
in  that  geographic  market.  Weakening economic  conditions  in
North  American  markets  has  also  resulted  in  fewer  orders,
particularly  for  equipment.  Higher  orders  were  received  in
international  markets,  where  economic  conditions  have   been
improving.

Backlog at the end of this year's third quarter was $41.8 million
compared with $45.2 million at the beginning of the fiscal  year,
with  the  decrease occurring primarily in the  Sign  Making  and
Specialty Graphics segment.  Order entry in this segment has been
dampened  by  previously  reported problems  experienced  in  the
introduction  of  the  Gerber  MAXX, a  new  wide-format  thermal
imaging system.  Currently the MAXX is on technical hold, and the
Company  expects  to  resume shipments in the  next  fiscal  year
beginning May 2001.

Company to Restructure Operations, Take Charge
----------------------------------------------

The   Company   today  announced  there  will  be  a  substantial
restructuring  of  its  worldwide operations  with  the  goal  of
reducing  operating  costs by $30 to $35  million  on  an  annual
basis. In conjunction with this, the Company anticipates a fourth-
quarter charge in the range of $20 to $22 million before taxes to
cover  the  costs  associated  with  severance,  plant  closings,
product  line terminations, and other asset write-downs. As  part
of   these  actions,  the  Company  anticipates  a  reduction  of
approximately 350 to 400 employees worldwide, or about 13  to  15
percent of its current workforce.

Review of Strategic Alternatives for Optical Business Continues
---------------------------------------------------------------

As  previously reported, the Company is considering  a  range  of
strategic alternatives, including potential divestiture, for  its
optical lens processing unit, Gerber Coburn.  The Company expects
to   complete  its  evaluation  of  all  potential  options   and
alternatives prior to fiscal year end on April 30, 2001.

Outlook:  Fourth Quarter Loss Expected; Earnings to Improve Next
Fiscal Year
----------------------------------------------------------------

The Company also said that it expects sales in the fourth quarter
ending April 30, 2001 will be in the range of $145.0 million with
a  net  loss estimated in the range of $.7 million, or  $.03  per
share,  before  any special charge.  Based upon these  estimates,
the  Company's  sales for the fiscal year ending April  30,  2001
would be approximately $560.0 million with a loss in the range of
$5.2  million, or $.23 per share.  These amounts are also  before
the  charge anticipated in the fourth quarter associated with the
restructuring  of  operations, but do  include  a  first  quarter
special  charge of $2.8 million after taxes, or $.13  per  share.
This  compares with sales of $611.0 million and earnings of $1.16
per diluted share in the prior year.

Given   current  economic  conditions,  the  Company  anticipates
limited top line growth in its next fiscal year beginning May  1,
2001.   Preliminary estimates for fiscal year 2002 are for  sales
in  the range of $560 to $565 million.  Based largely on benefits
derived from the restructuring actions being taken in the  fourth
quarter, the Company anticipates earnings per share in the  range
of $.45 to $.50 next fiscal year.

Gerber Scientific, Inc. (http://www.gerberscientific.com) is  the
world's leading supplier of sophisticated automated manufacturing
systems  that  enable  mass  customization  in  sign  making  and
specialty graphics, apparel and flexible goods, and optical  lens
processing.   Headquartered  in South Windsor,  Connecticut,  the
Company operates through four wholly-owned subsidiaries:   Gerber
Scientific  Products  and  Spandex PLC,  Gerber  Technology,  and
Gerber Coburn.

In addition to the historical information contained herein, there
are  matters discussed that are considered to be "forward looking
statements."   The Private Securities Litigation  Reform  Act  of
1995  provides  a  "safe harbor" for forward-looking  statements.
These forward looking statements involve risks and uncertainties,
including,   but   not   limited   to,   economic,   competitive,
governmental,  and technological factors affecting the  Company's
operations,   markets,   products,  and  services,   that   could
significantly affect results in the future.  For a discussion  of
other  risk factors relating to the Company's business,  see  the
Company's  Quarterly Reports on Form 10-Q for the quarters  ended
July  31, 2000 and October 31, 2000 and its Annual Report on Form
10-K  for  the  year  ended April 30, 2000,  as  filed  with  the
Securities   and   Exchange   Commission.   The   forward-looking
statements contained in this release are made as of the  date  of
this release, and the Company assumes no obligation to update  or
revise any forward-looking statements contained in this release.
GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                  CONSOLIDATED SUMMARY OF EARNINGS

Comparison on a consolidated basis for the three and nine months ended
January 31, 2001 and 2000 as follows:

THIRD QUARTER FINANCIAL FIGURES FOR THREE AND NINE MONTHS ENDED
JANUARY 31, 2001 AND 2000
---------------------------------------------------------------------------
                           Three Months                 Nine Months
                     --------------------------  --------------------------
                             2001          2000          2001          2000
                     ------------  ------------  ------------  ------------

Sales                $134,245,000  $155,543,000  $415,489,000  $447,872,000
                      ===========   ===========   ===========   ===========
Earnings (loss)
 before special
 charge (1)          $ (2,940,000) $ 12,174,000  $    229,000  $ 36,557,000
Special charge (1)             --            --    (4,419,000)           --
                      -----------   -----------   -----------   -----------
Earnings (loss)
 before income
 taxes               $ (2,940,000) $ 12,174,000  $ (4,190,000) $ 36,557,000
                      -----------   -----------   -----------   -----------
Taxes on earnings
 before special
 charge (2)          $   (700,000) $ (3,900,000) $ (1,900,000) $(12,400,000)
Tax benefit on
 special charge                --            --     1,600,000            --
                      -----------   -----------   -----------   -----------
Provision for
 income taxes        $   (700,000) $ (3,900,000) $   (300,000) $(12,400,000)
                      -----------   -----------   -----------   -----------
Net earnings (loss)
 before special
 charge (1)          $ (3,640,000) $  8,274,000  $ (1,671,000) $ 24,157,000
Special charge, net
 of taxes (1)                  --            --    (2,819,000)           --
                      -----------   -----------   -----------   -----------
Net earnings (loss)  $ (3,640,000) $  8,274,000  $ (4,490,000) $ 24,157,000
                      ===========   ===========   ===========   ===========

Per Share of Common Stock

Basic (3)
 Before special
  charge             $       (.17) $        .37  $       (.08) $       1.09
 Special charge                --            --          (.13)           --
                      -----------   -----------   -----------   -----------
                     $       (.17) $        .37  $       (.20) $       1.09
                      ===========   ===========   ===========   ===========
Diluted (3)
 Before special
  charge             $       (.17) $        .37  $       (.08) $       1.08
 Special charge                --            --          (.13)           --
                      -----------   -----------   -----------   -----------
                     $       (.17) $        .37  $       (.20) $       1.08
                      ===========   ===========   ===========   ===========

Average Shares Outstanding

Basic                  22,025,000    22,193,000    22,010,000    22,167,000
                      ===========   ===========   ===========   ===========
Diluted                22,025,000    22,411,000    22,010,000    22,450,000
                      ===========   ===========   ===========   ===========

(1)   Included  in  the nine months ended January  31,  2001  was  a
special  charge related to a reduction in workforce, provisions  for
losses on the sale of facilities, and other asset impairments.  This
charge  amounted  to $4,419,000 before income taxes  and  $2,819,000
after taxes ($.13 per share on a diluted basis.)

(2)   The  income tax  expense in the third  quarter and nine months
ended January 31, 2001 arises principally from the non-deductibility
of goodwill amortization.

(3)   Earnings per share information is computed separately for each
period.   Therefore,  the sum of such quarterly  share  amounts  may
differ from the total for the year.
GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                 CONSOLIDATED STATEMENTS OF EARNINGS

                                          Three Months Ended
In thousands (except per share amounts)      January 31,
--------------------------------------   ---------------------
                                             2001         2000
                                         --------     --------
Revenue:

  Product sales                          $122,056     $141,997
  Service                                  12,189       13,546
                                          -------      -------
                                          134,245      155,543
                                          -------      -------

Costs and Expenses:

  Cost of product sales                    79,639       84,916
  Cost of service                           7,997        7,080
  Selling, general and administrative      36,937       38,534
  Research and development expenses         7,256        7,982
  Goodwill amortization                     2,237        2,103
                                          -------      -------
                                          134,066      140,615
                                          -------      -------

Operating income                              179       14,928

Other income (expense)                        289          (21)
Interest expense                           (3,408)      (2,733)
                                          -------      -------

Earnings (loss) before income taxes        (2,940)      12,174

Provision for income taxes                    700        3,900
                                          -------      -------
Net earnings (loss)                      $ (3,640)    $  8,274
                                          =======      =======
Per share of common stock:
  Basic                                  $   (.17)    $    .37
  Diluted                                $   (.17)    $    .37

  Dividends                              $    .08     $    .08

Average shares outstanding:
  Basic                                    22,025       22,193
  Diluted                                  22,025       22,411

                       See Accompanying Notes
GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                 CONSOLIDATED STATEMENTS OF EARNINGS

                                           Nine Months Ended
In thousands (except per share amounts)       January 31,
--------------------------------------   ---------------------
                                             2001         2000
                                         --------     --------
Revenue:

  Product sales                          $378,477     $407,451
  Service                                  37,012       40,421
                                          -------      -------
                                          415,489      447,872
                                          -------      -------

Costs and Expenses:

  Cost of product sales                   243,331      239,949
  Cost of service                          24,335       21,573
  Selling, general and administrative     108,706      112,068
  Research and development expenses        22,526       24,884
  Goodwill amortization                     6,713        6,353
  Special charge                            4,419           --
                                          -------      -------
                                          410,030      404,827
                                          -------      -------

Operating income                            5,459       43,045

Other income                                  395        1,116
Interest expense                          (10,044)      (7,604)
                                          -------      -------

Earnings (loss) before income taxes        (4,190)      36,557

Provision for income taxes                    300       12,400
                                          -------      -------
Net earnings (loss)                      $ (4,490)    $ 24,157
                                          =======      =======
Per share of common stock:
  Basic                                  $   (.20)    $   1.09
  Diluted                                $   (.20)    $   1.08

  Dividends                              $    .24     $    .24

Average shares outstanding:
  Basic                                    22,010       22,167
  Diluted                                  22,010       22,450

                       See Accompanying Notes
GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                     CONSOLIDATED BALANCE SHEETS

                                        January 31,    April 30,
In thousands                               2001           2000
-------------------------------------   -----------    ---------
Assets
Current Assets:
 Cash and short-term cash investments      $ 14,327     $ 22,954
 Accounts receivable                        100,319      121,494
 Inventories                                 89,727       86,472
 Prepaid expenses                            18,756       21,042
 Net assets held for sale                    23,270           --
                                            -------      -------
                                            246,399      251,962
                                            -------      -------
Property, Plant and Equipment               118,590      165,341
 Less accumulated depreciation               54,767       66,121
                                            -------      -------
                                             63,823       99,220
                                            -------      -------
Intangible Assets                           246,033      245,797
 Less accumulated amortization               34,829       27,419
                                            -------      -------
                                            211,204      218,378
                                            -------      -------
Other Assets                                  4,498        3,276
                                            -------      -------
                                           $525,924     $572,836
                                            =======      =======
Liabilities and Shareholders' Equity

Current Liabilities:
 Notes payable                             $     --    $      --
 Accounts payable                            48,752       58,043
 Accrued compensation and benefits           12,498       16,646
 Other accrued liabilities                   27,935       26,689
 Deferred revenue                             9,513        8,436
 Advances on sales contracts                  2,715        2,610
                                            -------      -------
                                            101,413      112,424
                                            -------      -------
Noncurrent Liabilities:
 Deferred income taxes                        8,295        8,608
 Long-term debt                             167,627      194,892
                                            -------      -------
                                            175,922      203,500
                                            -------      -------

Contingencies and Commitments

Shareholders' Equity:
 Preferred stock, no par value;
  authorized 10,000,000 shares;
  no shares issued                               --          --
 Common stock, $1.00 par value;
  authorized 65,000,000 shares;
  issued 22,827,309 and 22,779,651
  shares                                     22,827      22,780
 Paid-in capital                             43,853      43,615
 Retained earnings                          200,984     210,749
 Treasury stock, at cost (788,899
  and 797,444 shares, respectively)         (16,222)    (16,397)
 Unamortized value of restricted
  stock grants                                 (552)       (557)
 Accumulated other comprehensive
  income(loss)                               (2,301)     (3,278)
                                            -------     -------
                                            248,589     256,912
                                            -------     -------
                                           $525,924    $572,836
                                            =======     =======

                       See Accompanying Notes
GERBER SCIENTIFIC, INC. AND SUBSIDIARIES
                CONSOLIDATED STATEMENTS OF CASH FLOWS

In thousands                                         2001       2000
---------------------------------------------    --------   --------
Cash Provided by (Used for):
Operating Activities:
  Net earnings (loss)                            $ (4,490)  $ 24,157
  Adjustments to reconcile net earnings
  (loss)to cash provided by operating
  activities:
     Depreciation and amortization                 20,827     18,665
     Special charge                                 4,419         --
     Deferred income taxes                           (313)    (1,730)
     Other non-cash items                             399        324
     Changes in operating accounts, net of
      effects of business acquisitions:
      Receivables                                  21,175     (7,310)
      Inventories                                  (3,255)   (19,965)
      Prepaid expenses                              2,231      5,638
      Accounts payable and accrued expenses       (15,682)    (5,564)
                                                   ------     ------
Provided by Operating Activities                   25,311     14,215
                                                   ------     ------
Investing Activities:
  Additions to property, plant and equipment      (14,245)   (18,091)
  Proceeds from sale of assets                     13,721         --
  Business acquisitions                                --    (11,026)
  Intangible and other assets                      (1,749)    (1,156)
  Other, net                                          977     (1,660)
                                                   ------     ------
(Used for) Investing Activities                    (1,296)   (31,933)
                                                   ------     ------
Financing Activities:
  Additions of long-term debt                      34,000     40,566
  Repayments of long-term debt                    (61,265)   (20,133)
  Net short-term financing                             --     (1,497)
  Debt issue costs                                   (168)        --
  Proceeds from issuance of stock                      66      1,938
  Dividends on common stock                        (5,275)    (5,312)
                                                   ------     ------
Provided by (Used for) Financing Activities       (32,642)    15,562
                                                   ------     ------
(Decrease) in Cash and Short-Term
  Cash Investments                                 (8,627)    (2,156)
Cash and Short-Term Cash Investments,
  Beginning of Period                              22,954     26,523
                                                   ------     ------
Cash and Short-Term Cash Investments,            $ 14,327   $ 24,367
  End of Period                                    ======     ======
                       See Accompanying Notes
SIGNATURES

Pursuant  to the requirements of the Securities Exchange  Act  of
1934, the Registrant has duly caused this report to be signed  on
its behalf by the undersigned hereunto duly authorized.

                            GERBER SCIENTIFIC, INC.
                            ------------------------
                                  (Registrant)

Date:   March 1, 2001       By:  / s / Gary K. Bennett
        ------------------       ---------------------------------
                                 Gary K. Bennett
                                 Senior Vice President, Finance
                                 (Principal Financial and
                                 Accounting Officer)